Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Antiviral Drugs Market: By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others; By Type; By Application; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Antiviral Drugs Market Outlook

The global antiviral drugs market attained a value of above USD 62.7 billion in 2021. The market is expected to witness a CAGR of 0.59% during 2022-2027.

 

Global Antiviral Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Represents a Considerable Share of the Antiviral Drugs Industry

The antiviral drugs industry is driven by the rising prevalence of viral infections and the increasing research and development (R&D) of antiviral drugs. North America holds a considerable market share of this sector, which can be attributed to the presence of major companies in the region. The widespread access to standard medical services in the region is also surging the demand for antiviral drugs, which is bolstering the market growth. Moreover, the introduction of various favourable government initiatives in the region is driving the market for antiviral drugs. For instance, in July 2021, the United States government announced an investment of more than USD 3 billion in the American Rescue Plan to accelerate the discovery, development and manufacturing of antiviral medicines.

Meanwhile, the Asia Pacific region is expected to grow due to the robustly developing healthcare and the introduction of favourable government initiatives. With the increasing manufacturing capacity of the pharmaceuticals in India and China, the market is poised to witness rapid growth in the forecast period.

 

Antiviral Drugs: Market Segmentation

Antiviral drugs are medications that are used to treat viral diseases by either killing the virus present or inhibiting the virus from replicating and spreading. Antiviral drugs are typically used to treat specific viruses. Moreover, broad-spectrum antiviral drugs are effective against a wide range of viruses.

 

Global Antiviral Drugs Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major drug classes of antiviral drugs are:

  • DNA Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Neuraminidase Inhibitors
  • Others

Based on type, the market is bifurcated into:

  • Branded
  • Generic

The market can be broadly categorised on the basis of its applications into:

  • HIV 
  • Hepatitis
  • Influenza
  • Herpes
  • Others

The EMR report looks into the regional markets of antiviral drugs like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Antiviral Drugs Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Challenges Associated with the Development of Antiviral Drugs to Hinder the Market Growth

The challenges associated with the development of antiviral drugs owing to mutations of viruses is hindering the market growth. Moreover, the development of antiviral drugs involves high investments, which is impeding the growth of the market. As the precise diagnosis of viral issues is difficult and the efficiency of antiviral drugs is limited to early treatment, the demand for antiviral drugs is reducing and obstructing the market growth.

As antiviral drugs have a narrow antiviral spectrum, their demand is reducing, which is negatively impacting the growth of the market. With the growing demand for alternative medicines such as naturopathy and homoeopathy, the market growth may witness a decline. The risk of toxic side effects from antiviral drugs is reducing their use and constraining the industry growth. The increasing ineffectiveness of antiviral drugs against latent viruses may impede the market growth in the forecast period.

 

Key Industry Players in the Global Antiviral Drugs Market

The report presents a detailed analysis of the following key players in the global antiviral drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • AbbVie Inc.
  • Merck and Co., Inc.
  • Johnson and Johnson Services, Inc.
  • Cipla Inc.
  • Bristol-Myers Squibb Company
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and
Forecast Market Analysis by Segment- Drug Class, Type, Application, Region
Breakup by Drug Class DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others
Breakup by Type Branded, Generics
Breakup by Application HIV, Hepatitis, Influenza, Herpes, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Gilead Sciences, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc.,
AbbVie Inc., Merck and Co., Inc., Johnson and Johnson Services, Inc., Cipla Inc., Bristol-Myers Squibb Company, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Antiviral Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Antiviral Drugs Historical Market (2017-2021) 
    8.3    Global Antiviral Drugs Market Forecast (2022-2027)
    8.4    Global Antiviral Drugs Market by Drug Class
        8.4.1    DNA Polymerase Inhibitors
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Reverse Transcriptase Inhibitors
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Protease Inhibitors
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Neuraminidase Inhibitors
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Others
    8.5    Global Antiviral Drugs Market by Type
        8.5.1    Branded
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Generics
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Antiviral Drugs Market by Application
        8.6.1    HIV
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Hepatitis
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Influenza
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Herpes
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Others
    8.7    Global Antiviral Drugs Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Gilead Sciences, Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    F. Hoffmann-La Roche AG
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    GlaxoSmithKline plc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    AbbVie Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Merck and Co., Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Johnson and Johnson Services, Inc.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Cipla Inc.
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Bristol-Myers Squibb Company
            12.2.8.1    Company Overview
            12.2.8.2    Product Portfolio
            12.2.8.3    Demographic Reach and Achievements
            12.2.8.4    Certifications
        12.2.9    Aurobindo Pharma Limited
            12.2.9.1    Company Overview
            12.2.9.2    Product Portfolio
            12.2.9.3    Demographic Reach and Achievements
            12.2.9.4    Certifications
        12.2.10    Dr. Reddy’s Laboratories Ltd.
            12.2.10.1    Company Overview
            12.2.10.2    Product Portfolio
            12.2.10.3    Demographic Reach and Achievements
            12.2.10.4    Certifications
        12.2.11    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Antiviral Drugs Market: Key Industry Highlights, 2017 and 2027
2.    Global Antiviral Drugs Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
3.    Global Antiviral Drugs Market Forecast: Breakup by Drug Class (USD Billion), 2021-202
4.    Global Antiviral Drugs Historical Market: Breakup by Type (USD Billion), 2017-2021
5.    Global Antiviral Drugs Market Forecast: Breakup by Type (USD Billion), 2022-2027
6.    Global Antiviral Drugs Historical Market: Breakup by Application (USD Billion), 2017-2021
7.    Global Antiviral Drugs Market Forecast: Breakup by Application (USD Billion), 2022-2027
8.    Global Antiviral Drugs Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Antiviral Drugs Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Antiviral Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Antiviral Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Antiviral Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Antiviral Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Antiviral Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Antiviral Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Antiviral Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Antiviral Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Antiviral Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Antiviral Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Antiviral Drugs Market Structure

Key Questions Answered in the Report

In 2021, the global antiviral drugs market attained a value of more than USD 62.7 billion.

The market is estimated to decline at a CAGR of 0.59% between 2022 and 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the market include the rising prevalence of viral infections, coupled with the rising healthcare expenditure in the emerging economies.

The growing R&D activities aimed towards developing efficient and cost-effective antiviral drugs is expected to be a key trend guiding the growth of the industry.

The major drug classes available in the market are DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and neuraminidase inhibitors, among others.

The different types of antiviral drugs are branded and generics.

The different applications of antiviral drugs are HIV, hepatitis, influenza, and herpes, among others.

The major players in the industry are Gilead Sciences, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., AbbVie Inc., Merck and Co., Inc., Johnson and Johnson Services, Inc., Cipla Inc., Bristol-Myers Squibb Company, Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories Ltd., among others.

Analyst Review

The global antiviral drugs market attained a value of more than USD 62.7 billion in 2021, driven by the rising cases of viral infections among the geriatrics, and rising healthcare expenditure. The market is expected to witness a CAGR of 0.59% during 2022-2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the market is divided into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and neuraminidase inhibitors, among others. On the basis of type, the market is divided into branded and generics. The significant applications of antiviral drugs include HIV, hepatitis, influenza, and herpes, among others. The major regional markets for antiviral drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Gilead Sciences, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., AbbVie Inc., Merck and Co., Inc., Johnson and Johnson Services, Inc., Cipla Inc., Bristol-Myers Squibb Company, Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER